— Know what they know.
Not Investment Advice

ROTH OTC

PharmaRoth Labs, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -90.0% 1Y: -90.0% 3Y: -99.8% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 48 · $3512 mcap · 287M float · 0.0000% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume20,000
Avg Volume24
Beta1.83
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOLuis Manuel Ornelas Lopez
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2009-06-16
8250 West Charleston Boulevard
Las Vegas, NV 89117
US
212-541-6222
About PharmaRoth Labs, Inc.

PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms